Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.
Related posts
-
‘So empowering’: Community blossoms through inclusive art project in Roselle
A Roselle sculpture project celebrates artists with special needs. -
United celebrates, American sues as city updates gate allocation at O’Hare
Who’s on first at O’Hare International Airport? Here’s a look at Chicago’s gate update as United... -
Why your ComEd bills are going up this month
Residential ComEd customers in Illinois will pay more for electricity starting this month, the utility confirmed...